Summary by Moomoo AI
Teng Sheng Bo Pharmaceutical Biotechnology Co., Ltd. filed its latest Securities Change Month Report with Hong Kong Trading and Settlement Limited on March 5, 2024, reporting the changes in the company's shares for the year ended February 29, 2024. The report showed that the company's regulated/registered share capital remained at 1,200,000,000 shares with a face value of $0.00005 per share and a total share capital of $6,000, unchanged this month. In addition, the Company details the exercise of share options under different share incentive schemes and share option plans, including the exercise price, the change in the number of options and the number of new shares that may be issued as a result of the exercise of options. The report noted that as of...Show More